Article
Molecular targets for liver cancer therapy: From screening of target genes to clinical trials
25 Sept 2009
Abstract excerpt
Cancer arises from the accumulation of genetic alterations, and the inactivation of oncogenes, or recovery of suppressor genes, are promising strategies for cancer treatment. Genome-based drug research starts with identification of target genes and is accomplished by exploitation of target-based drugs such as monoclonal antibodies, small molecules and antisense drugs. Recently, clinical trials for treatment of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
